Exact Sciences Corp

EXK

Company Profile

  • Business description

    Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

  • Contact

    5505 Endeavor Lane
    MadisonWI53719
    USA

    T: +1 608 284-5700

    E: [email protected]

    https://www.exactsciences.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    7,000

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,833.604.900.06%
CAC 407,760.3321.910.28%
DAX 4023,920.93130.820.55%
Dow JONES (US)44,726.87242.450.55%
FTSE 1008,817.3042.610.49%
HKSE24,069.94151.47-0.63%
NASDAQ20,540.94147.810.72%
Nikkei 22539,785.9023.420.06%
NZX 50 Index12,704.4879.81-0.62%
S&P 5006,264.6737.250.60%
S&P/ASX 2008,595.801.90-0.02%
SSE Composite Index3,461.156.360.18%

Market Movers